0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Short-Acting Anesthetic Market Research Report 2025
Published Date: 2025-02-13
|
Report Code: QYRE-Auto-8D19061
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Short Acting Anesthetic Market Research Report 2025
BUY CHAPTERS

Global Short-Acting Anesthetic Market Research Report 2025

Code: QYRE-Auto-8D19061
Report
2025-02-13
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Short-Acting Anesthetic Market Size

The global market for Short-Acting Anesthetic was valued at US$ 1266 million in the year 2024 and is projected to reach a revised size of US$ 1779 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Short-Acting Anesthetic Market

Short-Acting Anesthetic Market

A short-acting anesthetic is a type of medication used to induce temporary anesthesia or sedation for a brief duration. These anesthetics are designed for quick onset and limited duration of action, making them suitable for minor procedures or situations where prolonged anesthesia is unnecessary. They act by temporarily blocking nerve signals or reducing brain activity to prevent pain perception.
North American market for Short-Acting Anesthetic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Short-Acting Anesthetic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Short-Acting Anesthetic include B. Braun, Fresenius-Kabi, Paion, Baxter Healthcare, SSY Group, Eisai, Baili-Pharm, Cisen Pharmaceutical, Yingke Biopharmaceutical, Septodont, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Short-Acting Anesthetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short-Acting Anesthetic.
The Short-Acting Anesthetic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short-Acting Anesthetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short-Acting Anesthetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Short-Acting Anesthetic Market Report

Report Metric Details
Report Name Short-Acting Anesthetic Market
Accounted market size in year US$ 1266 million
Forecasted market size in 2031 US$ 1779 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Local
  • General
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun, Fresenius-Kabi, Paion, Baxter Healthcare, SSY Group, Eisai, Baili-Pharm, Cisen Pharmaceutical, Yingke Biopharmaceutical, Septodont, AstraZeneca, Pfizer, AbbVie, Piramal Critical Care, Hikma Pharmaceuticals, Aspen Pharmacare, Hospira, Dr. Reddy's Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Short-Acting Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Short-Acting Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Short-Acting Anesthetic Market growing?

Ans: The Short-Acting Anesthetic Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Short-Acting Anesthetic Market size in 2031?

Ans: The Short-Acting Anesthetic Market size in 2031 will be US$ 1779 million.

Who are the main players in the Short-Acting Anesthetic Market report?

Ans: The main players in the Short-Acting Anesthetic Market are B. Braun, Fresenius-Kabi, Paion, Baxter Healthcare, SSY Group, Eisai, Baili-Pharm, Cisen Pharmaceutical, Yingke Biopharmaceutical, Septodont, AstraZeneca, Pfizer, AbbVie, Piramal Critical Care, Hikma Pharmaceuticals, Aspen Pharmacare, Hospira, Dr. Reddy's Laboratories

What are the Application segmentation covered in the Short-Acting Anesthetic Market report?

Ans: The Applications covered in the Short-Acting Anesthetic Market report are Hospital, Clinic

What are the Type segmentation covered in the Short-Acting Anesthetic Market report?

Ans: The Types covered in the Short-Acting Anesthetic Market report are Local, General

1 Short-Acting Anesthetic Market Overview
1.1 Product Definition
1.2 Short-Acting Anesthetic by Type
1.2.1 Global Short-Acting Anesthetic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Local
1.2.3 General
1.3 Short-Acting Anesthetic by Application
1.3.1 Global Short-Acting Anesthetic Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Short-Acting Anesthetic Market Size Estimates and Forecasts
1.4.1 Global Short-Acting Anesthetic Revenue 2020-2031
1.4.2 Global Short-Acting Anesthetic Sales 2020-2031
1.4.3 Global Short-Acting Anesthetic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Short-Acting Anesthetic Market Competition by Manufacturers
2.1 Global Short-Acting Anesthetic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Short-Acting Anesthetic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Short-Acting Anesthetic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Short-Acting Anesthetic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short-Acting Anesthetic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short-Acting Anesthetic, Product Type & Application
2.7 Global Key Manufacturers of Short-Acting Anesthetic, Date of Enter into This Industry
2.8 Global Short-Acting Anesthetic Market Competitive Situation and Trends
2.8.1 Global Short-Acting Anesthetic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short-Acting Anesthetic Players Market Share by Revenue
2.8.3 Global Short-Acting Anesthetic Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short-Acting Anesthetic Market Scenario by Region
3.1 Global Short-Acting Anesthetic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Short-Acting Anesthetic Sales by Region: 2020-2031
3.2.1 Global Short-Acting Anesthetic Sales by Region: 2020-2025
3.2.2 Global Short-Acting Anesthetic Sales by Region: 2026-2031
3.3 Global Short-Acting Anesthetic Revenue by Region: 2020-2031
3.3.1 Global Short-Acting Anesthetic Revenue by Region: 2020-2025
3.3.2 Global Short-Acting Anesthetic Revenue by Region: 2026-2031
3.4 North America Short-Acting Anesthetic Market Facts & Figures by Country
3.4.1 North America Short-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Short-Acting Anesthetic Sales by Country (2020-2031)
3.4.3 North America Short-Acting Anesthetic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Short-Acting Anesthetic Market Facts & Figures by Country
3.5.1 Europe Short-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Short-Acting Anesthetic Sales by Country (2020-2031)
3.5.3 Europe Short-Acting Anesthetic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short-Acting Anesthetic Market Facts & Figures by Region
3.6.1 Asia Pacific Short-Acting Anesthetic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Short-Acting Anesthetic Sales by Region (2020-2031)
3.6.3 Asia Pacific Short-Acting Anesthetic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Short-Acting Anesthetic Market Facts & Figures by Country
3.7.1 Latin America Short-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Short-Acting Anesthetic Sales by Country (2020-2031)
3.7.3 Latin America Short-Acting Anesthetic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Short-Acting Anesthetic Market Facts & Figures by Country
3.8.1 Middle East and Africa Short-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Short-Acting Anesthetic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Short-Acting Anesthetic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short-Acting Anesthetic Sales by Type (2020-2031)
4.1.1 Global Short-Acting Anesthetic Sales by Type (2020-2025)
4.1.2 Global Short-Acting Anesthetic Sales by Type (2026-2031)
4.1.3 Global Short-Acting Anesthetic Sales Market Share by Type (2020-2031)
4.2 Global Short-Acting Anesthetic Revenue by Type (2020-2031)
4.2.1 Global Short-Acting Anesthetic Revenue by Type (2020-2025)
4.2.2 Global Short-Acting Anesthetic Revenue by Type (2026-2031)
4.2.3 Global Short-Acting Anesthetic Revenue Market Share by Type (2020-2031)
4.3 Global Short-Acting Anesthetic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Short-Acting Anesthetic Sales by Application (2020-2031)
5.1.1 Global Short-Acting Anesthetic Sales by Application (2020-2025)
5.1.2 Global Short-Acting Anesthetic Sales by Application (2026-2031)
5.1.3 Global Short-Acting Anesthetic Sales Market Share by Application (2020-2031)
5.2 Global Short-Acting Anesthetic Revenue by Application (2020-2031)
5.2.1 Global Short-Acting Anesthetic Revenue by Application (2020-2025)
5.2.2 Global Short-Acting Anesthetic Revenue by Application (2026-2031)
5.2.3 Global Short-Acting Anesthetic Revenue Market Share by Application (2020-2031)
5.3 Global Short-Acting Anesthetic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Company Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 B. Braun Short-Acting Anesthetic Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius-Kabi Short-Acting Anesthetic Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 Paion
6.3.1 Paion Company Information
6.3.2 Paion Description and Business Overview
6.3.3 Paion Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Paion Short-Acting Anesthetic Product Portfolio
6.3.5 Paion Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Healthcare Short-Acting Anesthetic Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 SSY Group
6.5.1 SSY Group Company Information
6.5.2 SSY Group Description and Business Overview
6.5.3 SSY Group Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SSY Group Short-Acting Anesthetic Product Portfolio
6.5.5 SSY Group Recent Developments/Updates
6.6 Eisai
6.6.1 Eisai Company Information
6.6.2 Eisai Description and Business Overview
6.6.3 Eisai Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eisai Short-Acting Anesthetic Product Portfolio
6.6.5 Eisai Recent Developments/Updates
6.7 Baili-Pharm
6.7.1 Baili-Pharm Company Information
6.7.2 Baili-Pharm Description and Business Overview
6.7.3 Baili-Pharm Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Baili-Pharm Short-Acting Anesthetic Product Portfolio
6.7.5 Baili-Pharm Recent Developments/Updates
6.8 Cisen Pharmaceutical
6.8.1 Cisen Pharmaceutical Company Information
6.8.2 Cisen Pharmaceutical Description and Business Overview
6.8.3 Cisen Pharmaceutical Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio
6.8.5 Cisen Pharmaceutical Recent Developments/Updates
6.9 Yingke Biopharmaceutical
6.9.1 Yingke Biopharmaceutical Company Information
6.9.2 Yingke Biopharmaceutical Description and Business Overview
6.9.3 Yingke Biopharmaceutical Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio
6.9.5 Yingke Biopharmaceutical Recent Developments/Updates
6.10 Septodont
6.10.1 Septodont Company Information
6.10.2 Septodont Description and Business Overview
6.10.3 Septodont Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Septodont Short-Acting Anesthetic Product Portfolio
6.10.5 Septodont Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Company Information
6.11.2 AstraZeneca Description and Business Overview
6.11.3 AstraZeneca Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 AstraZeneca Short-Acting Anesthetic Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Short-Acting Anesthetic Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 AbbVie
6.13.1 AbbVie Company Information
6.13.2 AbbVie Description and Business Overview
6.13.3 AbbVie Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AbbVie Short-Acting Anesthetic Product Portfolio
6.13.5 AbbVie Recent Developments/Updates
6.14 Piramal Critical Care
6.14.1 Piramal Critical Care Company Information
6.14.2 Piramal Critical Care Description and Business Overview
6.14.3 Piramal Critical Care Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Piramal Critical Care Short-Acting Anesthetic Product Portfolio
6.14.5 Piramal Critical Care Recent Developments/Updates
6.15 Hikma Pharmaceuticals
6.15.1 Hikma Pharmaceuticals Company Information
6.15.2 Hikma Pharmaceuticals Description and Business Overview
6.15.3 Hikma Pharmaceuticals Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio
6.15.5 Hikma Pharmaceuticals Recent Developments/Updates
6.16 Aspen Pharmacare
6.16.1 Aspen Pharmacare Company Information
6.16.2 Aspen Pharmacare Description and Business Overview
6.16.3 Aspen Pharmacare Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Aspen Pharmacare Short-Acting Anesthetic Product Portfolio
6.16.5 Aspen Pharmacare Recent Developments/Updates
6.17 Hospira
6.17.1 Hospira Company Information
6.17.2 Hospira Description and Business Overview
6.17.3 Hospira Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hospira Short-Acting Anesthetic Product Portfolio
6.17.5 Hospira Recent Developments/Updates
6.18 Dr. Reddy's Laboratories
6.18.1 Dr. Reddy's Laboratories Company Information
6.18.2 Dr. Reddy's Laboratories Description and Business Overview
6.18.3 Dr. Reddy's Laboratories Short-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio
6.18.5 Dr. Reddy's Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short-Acting Anesthetic Industry Chain Analysis
7.2 Short-Acting Anesthetic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short-Acting Anesthetic Production Mode & Process Analysis
7.4 Short-Acting Anesthetic Sales and Marketing
7.4.1 Short-Acting Anesthetic Sales Channels
7.4.2 Short-Acting Anesthetic Distributors
7.5 Short-Acting Anesthetic Customer Analysis
8 Short-Acting Anesthetic Market Dynamics
8.1 Short-Acting Anesthetic Industry Trends
8.2 Short-Acting Anesthetic Market Drivers
8.3 Short-Acting Anesthetic Market Challenges
8.4 Short-Acting Anesthetic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Short-Acting Anesthetic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Short-Acting Anesthetic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Short-Acting Anesthetic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Short-Acting Anesthetic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Short-Acting Anesthetic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Short-Acting Anesthetic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Short-Acting Anesthetic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Short-Acting Anesthetic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Short-Acting Anesthetic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Short-Acting Anesthetic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Short-Acting Anesthetic, Product Type & Application
 Table 12. Global Key Manufacturers of Short-Acting Anesthetic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Short-Acting Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short-Acting Anesthetic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Short-Acting Anesthetic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Short-Acting Anesthetic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Short-Acting Anesthetic Sales Market Share by Region (2020-2025)
 Table 19. Global Short-Acting Anesthetic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Short-Acting Anesthetic Sales Market Share by Region (2026-2031)
 Table 21. Global Short-Acting Anesthetic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Short-Acting Anesthetic Revenue Market Share by Region (2020-2025)
 Table 23. Global Short-Acting Anesthetic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Short-Acting Anesthetic Revenue Market Share by Region (2026-2031)
 Table 25. North America Short-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Short-Acting Anesthetic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Short-Acting Anesthetic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Short-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Short-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Short-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Short-Acting Anesthetic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Short-Acting Anesthetic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Short-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Short-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Short-Acting Anesthetic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Short-Acting Anesthetic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Short-Acting Anesthetic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Short-Acting Anesthetic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Short-Acting Anesthetic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Short-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Short-Acting Anesthetic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Short-Acting Anesthetic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Short-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Short-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Short-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Short-Acting Anesthetic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Short-Acting Anesthetic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Short-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Short-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Short-Acting Anesthetic Sales (K Units) by Type (2020-2025)
 Table 51. Global Short-Acting Anesthetic Sales (K Units) by Type (2026-2031)
 Table 52. Global Short-Acting Anesthetic Sales Market Share by Type (2020-2025)
 Table 53. Global Short-Acting Anesthetic Sales Market Share by Type (2026-2031)
 Table 54. Global Short-Acting Anesthetic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Short-Acting Anesthetic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Short-Acting Anesthetic Revenue Market Share by Type (2020-2025)
 Table 57. Global Short-Acting Anesthetic Revenue Market Share by Type (2026-2031)
 Table 58. Global Short-Acting Anesthetic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Short-Acting Anesthetic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Short-Acting Anesthetic Sales (K Units) by Application (2020-2025)
 Table 61. Global Short-Acting Anesthetic Sales (K Units) by Application (2026-2031)
 Table 62. Global Short-Acting Anesthetic Sales Market Share by Application (2020-2025)
 Table 63. Global Short-Acting Anesthetic Sales Market Share by Application (2026-2031)
 Table 64. Global Short-Acting Anesthetic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Short-Acting Anesthetic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Short-Acting Anesthetic Revenue Market Share by Application (2020-2025)
 Table 67. Global Short-Acting Anesthetic Revenue Market Share by Application (2026-2031)
 Table 68. Global Short-Acting Anesthetic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Short-Acting Anesthetic Price (US$/Unit) by Application (2026-2031)
 Table 70. B. Braun Company Information
 Table 71. B. Braun Description and Business Overview
 Table 72. B. Braun Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. B. Braun Short-Acting Anesthetic Product
 Table 74. B. Braun Recent Developments/Updates
 Table 75. Fresenius-Kabi Company Information
 Table 76. Fresenius-Kabi Description and Business Overview
 Table 77. Fresenius-Kabi Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Fresenius-Kabi Short-Acting Anesthetic Product
 Table 79. Fresenius-Kabi Recent Developments/Updates
 Table 80. Paion Company Information
 Table 81. Paion Description and Business Overview
 Table 82. Paion Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Paion Short-Acting Anesthetic Product
 Table 84. Paion Recent Developments/Updates
 Table 85. Baxter Healthcare Company Information
 Table 86. Baxter Healthcare Description and Business Overview
 Table 87. Baxter Healthcare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter Healthcare Short-Acting Anesthetic Product
 Table 89. Baxter Healthcare Recent Developments/Updates
 Table 90. SSY Group Company Information
 Table 91. SSY Group Description and Business Overview
 Table 92. SSY Group Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. SSY Group Short-Acting Anesthetic Product
 Table 94. SSY Group Recent Developments/Updates
 Table 95. Eisai Company Information
 Table 96. Eisai Description and Business Overview
 Table 97. Eisai Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Eisai Short-Acting Anesthetic Product
 Table 99. Eisai Recent Developments/Updates
 Table 100. Baili-Pharm Company Information
 Table 101. Baili-Pharm Description and Business Overview
 Table 102. Baili-Pharm Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Baili-Pharm Short-Acting Anesthetic Product
 Table 104. Baili-Pharm Recent Developments/Updates
 Table 105. Cisen Pharmaceutical Company Information
 Table 106. Cisen Pharmaceutical Description and Business Overview
 Table 107. Cisen Pharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cisen Pharmaceutical Short-Acting Anesthetic Product
 Table 109. Cisen Pharmaceutical Recent Developments/Updates
 Table 110. Yingke Biopharmaceutical Company Information
 Table 111. Yingke Biopharmaceutical Description and Business Overview
 Table 112. Yingke Biopharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Yingke Biopharmaceutical Short-Acting Anesthetic Product
 Table 114. Yingke Biopharmaceutical Recent Developments/Updates
 Table 115. Septodont Company Information
 Table 116. Septodont Description and Business Overview
 Table 117. Septodont Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Septodont Short-Acting Anesthetic Product
 Table 119. Septodont Recent Developments/Updates
 Table 120. AstraZeneca Company Information
 Table 121. AstraZeneca Description and Business Overview
 Table 122. AstraZeneca Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. AstraZeneca Short-Acting Anesthetic Product
 Table 124. AstraZeneca Recent Developments/Updates
 Table 125. Pfizer Company Information
 Table 126. Pfizer Description and Business Overview
 Table 127. Pfizer Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Pfizer Short-Acting Anesthetic Product
 Table 129. Pfizer Recent Developments/Updates
 Table 130. AbbVie Company Information
 Table 131. AbbVie Description and Business Overview
 Table 132. AbbVie Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. AbbVie Short-Acting Anesthetic Product
 Table 134. AbbVie Recent Developments/Updates
 Table 135. Piramal Critical Care Company Information
 Table 136. Piramal Critical Care Description and Business Overview
 Table 137. Piramal Critical Care Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Piramal Critical Care Short-Acting Anesthetic Product
 Table 139. Piramal Critical Care Recent Developments/Updates
 Table 140. Hikma Pharmaceuticals Company Information
 Table 141. Hikma Pharmaceuticals Description and Business Overview
 Table 142. Hikma Pharmaceuticals Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hikma Pharmaceuticals Short-Acting Anesthetic Product
 Table 144. Hikma Pharmaceuticals Recent Developments/Updates
 Table 145. Aspen Pharmacare Company Information
 Table 146. Aspen Pharmacare Description and Business Overview
 Table 147. Aspen Pharmacare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Aspen Pharmacare Short-Acting Anesthetic Product
 Table 149. Aspen Pharmacare Recent Developments/Updates
 Table 150. Hospira Company Information
 Table 151. Hospira Description and Business Overview
 Table 152. Hospira Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Hospira Short-Acting Anesthetic Product
 Table 154. Hospira Recent Developments/Updates
 Table 155. Dr. Reddy's Laboratories Company Information
 Table 156. Dr. Reddy's Laboratories Description and Business Overview
 Table 157. Dr. Reddy's Laboratories Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Dr. Reddy's Laboratories Short-Acting Anesthetic Product
 Table 159. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Short-Acting Anesthetic Distributors List
 Table 163. Short-Acting Anesthetic Customers List
 Table 164. Short-Acting Anesthetic Market Trends
 Table 165. Short-Acting Anesthetic Market Drivers
 Table 166. Short-Acting Anesthetic Market Challenges
 Table 167. Short-Acting Anesthetic Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Short-Acting Anesthetic
 Figure 2. Global Short-Acting Anesthetic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Short-Acting Anesthetic Market Share by Type: 2024 & 2031
 Figure 4. Local Product Picture
 Figure 5. General Product Picture
 Figure 6. Global Short-Acting Anesthetic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Short-Acting Anesthetic Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Short-Acting Anesthetic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Short-Acting Anesthetic Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Short-Acting Anesthetic Sales (2020-2031) & (K Units)
 Figure 13. Global Short-Acting Anesthetic Average Price (US$/Unit) & (2020-2031)
 Figure 14. Short-Acting Anesthetic Report Years Considered
 Figure 15. Short-Acting Anesthetic Sales Share by Manufacturers in 2024
 Figure 16. Global Short-Acting Anesthetic Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Short-Acting Anesthetic Players: Market Share by Revenue in Short-Acting Anesthetic in 2024
 Figure 18. Short-Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Short-Acting Anesthetic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Short-Acting Anesthetic Sales Market Share by Country (2020-2031)
 Figure 21. North America Short-Acting Anesthetic Revenue Market Share by Country (2020-2031)
 Figure 22. United States Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Short-Acting Anesthetic Sales Market Share by Country (2020-2031)
 Figure 25. Europe Short-Acting Anesthetic Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Short-Acting Anesthetic Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Short-Acting Anesthetic Revenue Market Share by Region (2020-2031)
 Figure 33. China Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Short-Acting Anesthetic Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Short-Acting Anesthetic Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Short-Acting Anesthetic Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Short-Acting Anesthetic Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Short-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Short-Acting Anesthetic by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Short-Acting Anesthetic by Type (2020-2031)
 Figure 53. Global Short-Acting Anesthetic Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Short-Acting Anesthetic by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Short-Acting Anesthetic by Application (2020-2031)
 Figure 56. Global Short-Acting Anesthetic Price (US$/Unit) by Application (2020-2031)
 Figure 57. Short-Acting Anesthetic Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS